OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. A variety of strategies have been employed enhance antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning culture c